Research programme: Cardio protective agents - GrindeksAlternative Names: GBB hydroxyls inhibitor - Grindeks; γ-butyrobetaine inhibitor - Grindeks
Latest Information Update: 03 Dec 2014
At a glance
- Originator Grindeks
- Mechanism of Action Gamma-butyrobetaine dioxygenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cardiovascular disorders